Melanoma conjuntival en niños | Revista Colombiana de Cancerología

Información del artículo

Resumen

Las lesiones melanocíticas de la conjuntiva abarcan un espectro que comprende desde nevus benignos y atípicos hasta el melanoma maligno. El melanoma conjuntival es un tumor poco común de personas adultas, con algunos casos reportados en niños. Las lesiones conjuntivales pigmentadas en niños son predominantemente nevus, y en raras ocasiones pueden sufrir transformación maligna. Se describirá el caso de una niña de 8 años con melanoma conjuntival, quien presentó antecedente de lesión pigmentada en la conjuntiva bulbar del ojo izquierdo desde los 3 años de edad, y la cual creció de forma progresiva.

Palabras clave:

Melanoma

niños

nevo

Abstract

Melanocytic lesions of the conjunctiva range from benign and atypical nevus to malignant melanoma. Conjuntival melanoma is an uncommon tumor among adults, and few cases have been reported in children. Pigmented conjuntival lesions in children are predominantly nevus, and on rare occasion can become malignant. A case is described of an 8-year old girl with conjuntival melanoma with antecedent of pigmented lesion in the bulbous conjunctiva of the left eye from age 3 which underwent progressive growth.

Key words:

Melanoma

childs

Nevus

El Texto completo está disponible en PDF

Referencias

[1.]

A. Zembowicz, R. Mandal, P. Choopong.

Melanocytic lesions of the conjunctiva.

Arch Pathol Lab Med., 134 (2010), pp. 1785-1792

http://dx.doi.org/10.1043/2009-0522-RAR.1 | Medline

[2.]

J.E. Ash.

Epibulbar tumors.

Am J Ophthalmol., 33 (1950), pp. 1203-1219

Medline

[3.]

C.L. Shields, H. Demirci, E. Karatza, et al.

Clinical survey of 1643 melanocytic and nonmelanocytic conjuntival tumors.

Ophthalmology., 111 (2004), pp. 1747-1754

http://dx.doi.org/10.1016/j.ophtha.2004.02.013 | Medline

[4.]

S. Pandela, E. Fonseca, V. Prieto.

Melanoma in children.

Arch Pathol Lab Med., 135 (2011), pp. 307-316

http://dx.doi.org/10.1043/2009-0503-RA.1 | Medline

[5.]

R.L. Barrnhill.

Pathology of melanocytic nevi and malignant melanoma.

2nd, Springer, (2004),

[6.]

J.H. Aldrink, M.A. Selim, D.L. Diesen, et al.

Pediatric melanoma: a single-institution experience of 150 patients.

J Pediatr Surg., 44 (2009), pp. 1514-1521

http://dx.doi.org/10.1016/j.jpedsurg.2008.12.003 | Medline

[7.]

S. Tuomaala, S. Eskelin, A. Tarkkanen, et al.

Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in Whites.

Invest Ophthalmol Vis Sci., 43 (2002), pp. 3399-3408

Medline

[8.]

S. Seregars.

Conjunctival melanoma.

Surv Ophthalmol., 42 (1998), pp. 321-350

Medline

[9.]

S. Yevgenly, W.W. Matthew.

Current opinion in ophthalmology., 21 (2010), pp. 380-386

http://dx.doi.org/10.1097/ICU.0b013e32833b7aab | Medline

[10.]

E. Triay, L. Bergman, B. Nilsson.

Time trends in the incidence of conjunctival in Sweden.

Br J Ophthalmol., 93 (2009), pp. 1524-1528

http://dx.doi.org/10.1136/bjo.2009.157933 | Medline

[11.]

G. Anastassiou, M. Esser, E. Bader, et al.

Expression of cell adhesion molecules and tumor infiltrating leucocytes in conjuntival melanoma.

Melanoma Res., 14 (2004), pp. 381-383

Medline

[12.]

G.P. Yu, D.N. Hu, S. Cormick, et al.

Conjunctival melanoma: is it increasing in the United States?.

Am J Ophthalmol., 135 (2003), pp. 800-806

Medline

[13.]

Shiels Cl, J.A. Shields.

Current opinion in ophthalmology., 18 (2007), pp. 351-360

http://dx.doi.org/10.1097/ICU.0b013e32823ecfbb | Medline

[14.]

S. Brownstein, H. Faraji, W.B. Jackson, et al.

Clinicopathologic reports, case reports, and small case series.

Arch Ophthalmol., 124 (2006), pp. 1190-1192

http://dx.doi.org/10.1001/archopht.124.8.1190 | Medline

[15.]

V.M.L. Cohen, S. Ahmadi-Lari, J.L. Hungerford.

Gastric metastases from conjunctival melanoma.

Melanoma Res., 17 (2007), pp. 255-256

http://dx.doi.org/10.1097/CMR.0b013e3281c4a056 | Medline

[16.]

H.E. Spendlove, B.E. Damato, J. Humphreys, et al.

BRAF mutations are detectable in conjunctival but not uveal melanomas.

Melanoma Res., 14 (2004), pp. 449-452

Medline

[17.]

H. Gear, H. Williams, E.G. Kemp, et al.

BRAF mutations in conjunctival melanoma.

Invest Ophthalmol Vis Sci., 45 (2004), pp. 2484-2488

http://dx.doi.org/10.1167/iovs.04-0093 | Medline

[18.]

S. Tuomaama, T. Kivela.

Conjunctival melanoma: is it increasing in the United States?.

Am J Ophthalmol., 136 (2003), pp. 1189-1190

Medline

[19.]

R. Folberg, I.W. McLean, L.E. Zimmerman.

Malignant melanoma of the conjunctiva.

Hum Pathol., 16 (1985), pp. 136-143

Medline

[20.]

S. Grover, D.S. Jacobs, K.A. Colby.

Boston ocular surface prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma.

Cornea., 29 (2010), pp. 459-461

http://dx.doi.org/10.1097/ICO.0b013e3181b55b40 | Medline

[21.]

A.D. Paridaens, D.C. Minasssian, A.C. Cartney, et al.

Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

Br J Ophthalmol., 78 (1994), pp. 252-259

Medline

[22.]

E. Furusato, A.A. Hidayat, Y.G. Man, et al.

WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva.

Arch Ophthalmol., 127 (2009), pp. 964-968

http://dx.doi.org/10.1001/archophthalmol.2009.183 | Medline

[23.]

F.A. Jakobiec, K. Colby, A.M. Bajart, et al.

Immunohistochemical studies of atypical conjnctival melanocytic nevi.

Arch Ophthalmol., 127 (2009), pp. 970-980

http://dx.doi.org/10.1001/archophthalmol.2009.171 | Medline

Indexada en:

Síguenos:

Indexada en:

Síguenos:

Suscríbase a la newsletter